
Barry Choobin
Examiner (ID: 2847)
| Most Active Art Unit | 2625 |
| Art Unit(s) | 2623, 2721, 2621, 2624, 2625 |
| Total Applications | 321 |
| Issued Applications | 267 |
| Pending Applications | 27 |
| Abandoned Applications | 27 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10685788
[patent_doc_number] => 20160031933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'AMINO ACIDS PRODUCED ACCORDING TO A PROCESS OF MECHANOCATALYTIC HYDROLYSIS OF PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 14/776500
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 11012
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14776500
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/776500 | AMINO ACIDS PRODUCED ACCORDING TO A PROCESS OF MECHANOCATALYTIC HYDROLYSIS OF PROTEINS | Mar 13, 2014 | Abandoned |
Array
(
[id] => 10684486
[patent_doc_number] => 20160030631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-04
[patent_title] => 'Injectable Biodegradable Bone Matrix for Multiple Myeloma Lesion Augmentation and Osteoporosis'
[patent_app_type] => utility
[patent_app_number] => 14/774500
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 10626
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774500
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/774500 | Injectable Biodegradable Bone Matrix for Multiple Myeloma Lesion Augmentation and Osteoporosis | Mar 12, 2014 | Abandoned |
Array
(
[id] => 10669710
[patent_doc_number] => 20160015855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'SURGICAL METHODS EMPLOYING PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 14/773262
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 34079
[patent_no_of_claims] => 88
[patent_no_of_ind_claims] => 40
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773262
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773262 | SURGICAL METHODS EMPLOYING PURIFIED AMPHIPHILIC PEPTIDE COMPOSITIONS | Mar 5, 2014 | Abandoned |
Array
(
[id] => 9699400
[patent_doc_number] => 20140249084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-04
[patent_title] => 'PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK IN A UNIT DOSE OF 100 TO 200 UNITS'
[patent_app_type] => utility
[patent_app_number] => 14/197607
[patent_app_country] => US
[patent_app_date] => 2014-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 18494
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14197607
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/197607 | PTH-CONTAINING THERAPEUTIC/PROPHYLACTIC AGENT FOR OSTEOPOROSIS, CHARACTERIZED IN THAT PTH IS ADMINISTERED ONCE A WEEK IN A UNIT DOSE OF 100 TO 200 UNITS | Mar 4, 2014 | Abandoned |
Array
(
[id] => 11894078
[patent_doc_number] => 09763998
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Serpins: methods of therapeutic β-cell regeneration and function'
[patent_app_type] => utility
[patent_app_number] => 14/186054
[patent_app_country] => US
[patent_app_date] => 2014-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 17
[patent_no_of_words] => 19846
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14186054
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/186054 | Serpins: methods of therapeutic β-cell regeneration and function | Feb 20, 2014 | Issued |
Array
(
[id] => 10483293
[patent_doc_number] => 20150368312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-24
[patent_title] => 'INSULIN SECRETING POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/767228
[patent_app_country] => US
[patent_app_date] => 2014-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 10797
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14767228
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/767228 | Insulin secreting polypeptides | Feb 12, 2014 | Issued |
Array
(
[id] => 10428993
[patent_doc_number] => 20150314003
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2015-11-05
[patent_title] => 'INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER'
[patent_app_type] => utility
[patent_app_number] => 14/179042
[patent_app_country] => US
[patent_app_date] => 2014-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 62640
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14179042
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/179042 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANONIC POLYMER | Feb 11, 2014 | Abandoned |
Array
(
[id] => 10428993
[patent_doc_number] => 20150314003
[patent_country] => US
[patent_kind] => A2
[patent_issue_date] => 2015-11-05
[patent_title] => 'INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER'
[patent_app_type] => utility
[patent_app_number] => 14/179042
[patent_app_country] => US
[patent_app_date] => 2014-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 62640
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14179042
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/179042 | INJECTABLE SOLUTION AT PH 7 COMPRISING AT LEAST ONE BASAL INSULIN THE ISOELECTRIC POINT OF WHICH IS BETWEEN 5.8 AND 8.5 AND A HYDROPHOBIZED ANIONIC POLYMER | Feb 11, 2014 | Abandoned |
Array
(
[id] => 9477793
[patent_doc_number] => 20140135256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'TREATMENT OF EXTRACELLULAR MATRIX TO REDUCE INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 14/159129
[patent_app_country] => US
[patent_app_date] => 2014-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 21759
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14159129
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/159129 | Treatment of extracellular matrix to reduce inflammation | Jan 19, 2014 | Issued |
Array
(
[id] => 10431532
[patent_doc_number] => 20150316544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-05
[patent_title] => 'RELEASABLE MAGNETIC CELL CAPTURE SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 14/653410
[patent_app_country] => US
[patent_app_date] => 2014-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5612
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14653410
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/653410 | RELEASABLE MAGNETIC CELL CAPTURE SYSTEM | Jan 13, 2014 | Abandoned |
Array
(
[id] => 10444598
[patent_doc_number] => 20150329612
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-19
[patent_title] => 'PROCESS FOR PURIFYING INSULIN AND ANALOGUES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/652494
[patent_app_country] => US
[patent_app_date] => 2013-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 7870
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14652494
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/652494 | Process for purifying insulin and analogues thereof | Dec 11, 2013 | Issued |
Array
(
[id] => 10399437
[patent_doc_number] => 20150284446
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'SYNTHETIC LINEAR APELIN MIMETICS FOR THE TREATMENT OF HEART FAILURE'
[patent_app_type] => utility
[patent_app_number] => 14/440198
[patent_app_country] => US
[patent_app_date] => 2013-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32476
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440198
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440198 | Synthetic linear apelin mimetics for the treatment of heart failure | Nov 18, 2013 | Issued |
Array
(
[id] => 9491739
[patent_doc_number] => 20140142145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'COMBINATIONS COMPRISING A DIPEPTIDYLPEPTIDASE - IV INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/075556
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12767
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075556
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075556 | COMBINATIONS COMPRISING A DIPEPTIDYLPEPTIDASE - IV INHIBITOR | Nov 7, 2013 | Abandoned |
Array
(
[id] => 9408192
[patent_doc_number] => 20140099444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-04-10
[patent_title] => 'COMPOSITES CONTAINING POLYPEPTIDES ATTACHED TO POLYSACCHARIDES AND MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 14/073833
[patent_app_country] => US
[patent_app_date] => 2013-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16351
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14073833
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/073833 | COMPOSITES CONTAINING POLYPEPTIDES ATTACHED TO POLYSACCHARIDES AND MOLECULES | Nov 5, 2013 | Abandoned |
Array
(
[id] => 10388061
[patent_doc_number] => 20150273069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY'
[patent_app_type] => utility
[patent_app_number] => 14/436126
[patent_app_country] => US
[patent_app_date] => 2013-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16746
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436126
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436126 | FATTY ACID ACYLATED AMINO ACIDS FOR ORAL PEPTIDE DELIVERY | Oct 15, 2013 | Abandoned |
Array
(
[id] => 9330142
[patent_doc_number] => 20140056924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-27
[patent_title] => 'GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA'
[patent_app_type] => utility
[patent_app_number] => 14/045332
[patent_app_country] => US
[patent_app_date] => 2013-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4954
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14045332
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/045332 | GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA | Oct 2, 2013 | Abandoned |
Array
(
[id] => 10325740
[patent_doc_number] => 20150210744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-30
[patent_title] => 'GLUCAGON ANALOGUES'
[patent_app_type] => utility
[patent_app_number] => 14/417074
[patent_app_country] => US
[patent_app_date] => 2013-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14451
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14417074
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/417074 | Glucagon analogues | Jul 22, 2013 | Issued |
Array
(
[id] => 10805355
[patent_doc_number] => 20160151512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'Cell-Penetrating Peptide, Conjugate Comprising Same and Composition Comprising Same'
[patent_app_type] => utility
[patent_app_number] => 14/413732
[patent_app_country] => US
[patent_app_date] => 2013-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 19249
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413732
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/413732 | Cell-penetrating peptide, conjugate comprising same and composition comprising same | Jul 10, 2013 | Issued |
Array
(
[id] => 10226827
[patent_doc_number] => 20150111820
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'NOVEL USE OF INSULIN DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/408066
[patent_app_country] => US
[patent_app_date] => 2013-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6860
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14408066
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/408066 | NOVEL USE OF INSULIN DERIVATIVES | Jul 7, 2013 | Abandoned |
Array
(
[id] => 11342380
[patent_doc_number] => 09526766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-27
[patent_title] => 'Potentiation of antibiotic treatment with a protein-lipid complex'
[patent_app_type] => utility
[patent_app_number] => 14/412104
[patent_app_country] => US
[patent_app_date] => 2013-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 23
[patent_no_of_words] => 25205
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412104
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412104 | Potentiation of antibiotic treatment with a protein-lipid complex | Jul 4, 2013 | Issued |